Awardee Organization(s): Kennesaw State University
Principal Investigator(s): Maria Valero, PhD, MsC | Katherine Ingram, PhD
Official Project Title: GlucoCheck: A Non-Invasive & AI-Assisted Blood Glucose Monitoring Device for Older Adults
AITC Partner: PennAITech
Website(s):
https://ccse.kennesaw.edu
Iotas.kennesaw.edu
The GlucoCheck project presents a significant advancement in the realm of diabetes management, with a specific focus on enhancing the quality of life for older adults. In light of the escalating global prevalence of diabetes and its associated complications, the imperative for non-invasive, accurate, and user-friendly blood glucose monitoring has never been more pronounced. Diabetes poses severe health risks, particularly for older adults, making effective and comfortable glucose monitoring paramount. Existing methods, characterized by frequent finger-pricking and subcutaneous needle implants, entail discomfort, infection risks, and potential tissue damage, particularly in individuals with diminished skin elasticity and compromised immune responses. GlucoCheck emerges as a pioneering solution, harnessing near-infrared spectroscopy (NIR) technology augmented by AI. This device offers a non-invasive means of consistently monitoring blood glucose levels by simply wearing it on one’s finger. Importantly, GlucoCheck integrates AI algorithms that adapt to individual skin attributes, including color and texture, enhancing precision across diverse demographics. This project’s core objectives encompass rigorous validation of GlucoCheck’s efficacy, with a primary emphasis on older adult demographic. Comparative analyses will be conducted, aligning GlucoCheck’s measurements with conventional blood glucose monitors to ascertain accuracy and reliability. Our mission is underscored by the desire to deliver an efficacious, user-centric device tailored to the unique requirements of older adults. The project’s outcomes will furnish valuable insights that drive refinements in GlucoCheck, propelling us closer to positively impacting the livesof millions of individuals grappling with diabetes.
View Resource